Orenitram: Medgend

Orenitram FDA Approved Drugs

ORENITRAM [Treprostinil Diolamine^{C₂₃H₃₄O₅C₄H₁₁NO₂}]

eq 0.125mg base (oral tablet, extended release)

eq 0.25mg base (oral tablet, extended release)

eq 1mg base (oral tablet, extended release)

eq 2.5mg base (oral tablet, extended release)

eq 5mg base (oral tablet, extended release)

United Therap^{Dec 20, 2013}

Method of treating pulmonary hypertension by orally administering a formulation of a pharmaceutically acceptable salt of treprostinil.
Use of orenitram for the treatment of pulmonary arterial hypertension (pah) (who group 1)..

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.